Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.2478/aiht-2022-73-3643

Resveratrol as antioxidant in cardiac surgery: is there potential for clinical application?

Mislav Planinc ; University Hospital Centre Zagreb, Department of Congenital Cardiac Surgery, Zagreb, Croatia
Ivana Novak Jovanović ; Institute for Medical Research and Occupational Health, Toxicology Unit, Zagreb, Croatia
Dubravka Rašić ; Institute for Medical Research and Occupational Health, Toxicology Unit, Zagreb, Croatia
Maja Peraica ; Institute for Medical Research and Occupational Health, Toxicology Unit, Zagreb, Croatia
Željko Sutlić ; University Hospital Dubrava, Department of Cardiac and Transplant Surgery, Zagreb, Croatia


Puni tekst: engleski pdf 186 Kb

str. 256-259

preuzimanja: 313

citiraj


Sažetak

Cardiopulmonary bypass (CPB) is an essential technique in cardiac surgery but is also associated with adverse effects, including the systemic inflammatory response syndrome that manifests itself as ischaemia-reperfusion injury and multi-organ dysfunction. The aim of this mini review is to take a look at the current knowledge of resveratrol, a stilbenoid and natural antioxidant believed to have many cardioprotective effects including vasodilation, lowering of blood pressure and reactive oxygen species levels, suppression of low-density lipoprotein peroxidation, and mitigation of ischaemia/-reperfusion injury. We mostly focus on its cardioprotective potential in patients undergoing cardiac surgery supported by CPB. Current findings, however, are still inconclusive and call for further research, including clinical trials

Ključne riječi

cardioprotective effects; cardiopulmonary bypass; ischaemia/reperfusion injury; polyphenols

Hrčak ID:

288078

URI

https://hrcak.srce.hr/288078

Datum izdavanja:

28.12.2022.

Podaci na drugim jezicima: hrvatski

Posjeta: 998 *

accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.